182 related articles for article (PubMed ID: 19322517)
1. In vitro dopaminergic neuroprotective and in vivo antiparkinsonian-like effects of Delta 3,2-hydroxybakuchiol isolated from Psoralea corylifolia (L.).
Zhao G; Zheng XW; Qin GW; Gai Y; Jiang ZH; Guo LH
Cell Mol Life Sci; 2009 May; 66(9):1617-29. PubMed ID: 19322517
[TBL] [Abstract][Full Text] [Related]
2. Bakuchiol analogs inhibit monoamine transporters and regulate monoaminergic functions.
Zhao G; Zang SY; Zheng XW; Zhang XH; Guo LH
Biochem Pharmacol; 2008 May; 75(9):1835-47. PubMed ID: 18329002
[TBL] [Abstract][Full Text] [Related]
3. Effects of green tea polyphenols on dopamine uptake and on MPP+ -induced dopamine neuron injury.
Pan T; Fei J; Zhou X; Jankovic J; Le W
Life Sci; 2003 Jan; 72(9):1073-83. PubMed ID: 12495785
[TBL] [Abstract][Full Text] [Related]
4. Dopamine transporter inhibitory and antiparkinsonian effect of common flowering quince extract.
Zhao G; Jiang ZH; Zheng XW; Zang SY; Guo LH
Pharmacol Biochem Behav; 2008 Sep; 90(3):363-71. PubMed ID: 18485464
[TBL] [Abstract][Full Text] [Related]
5. Inhibitive effects of Fructus Psoraleae extract on dopamine transporter and noradrenaline transporter.
Zhao G; Li S; Qin GW; Fei J; Guo LH
J Ethnopharmacol; 2007 Jul; 112(3):498-506. PubMed ID: 17555897
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole.
Joyce JN; Presgraves S; Renish L; Borwege S; Osredkar T; Hagner D; Replogle M; PazSoldan M; Millan MJ
Exp Neurol; 2003 Nov; 184(1):393-407. PubMed ID: 14637109
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
Pariyar R; Bastola T; Lee DH; Seo J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
[TBL] [Abstract][Full Text] [Related]
8. Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism.
Muñoz A; Rey P; Guerra MJ; Mendez-Alvarez E; Soto-Otero R; Labandeira-Garcia JL
Neuropharmacology; 2006 Jul; 51(1):112-20. PubMed ID: 16678218
[TBL] [Abstract][Full Text] [Related]
9. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
10. Morin exerts neuroprotective actions in Parkinson disease models in vitro and in vivo.
Zhang ZT; Cao XB; Xiong N; Wang HC; Huang JS; Sun SG; Wang T
Acta Pharmacol Sin; 2010 Aug; 31(8):900-6. PubMed ID: 20644549
[TBL] [Abstract][Full Text] [Related]
11. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
[TBL] [Abstract][Full Text] [Related]
12. Peripheral Administration of Tetanus Toxin Hc Fragment Prevents MPP
Moreno-Galarza N; Mendieta L; Palafox-Sánchez V; Herrando-Grabulosa M; Gil C; Limón DI; Aguilera J
Neurotox Res; 2018 Jul; 34(1):47-61. PubMed ID: 29460114
[TBL] [Abstract][Full Text] [Related]
13. Activation of transcription factor MEF2D by bis(3)-cognitin protects dopaminergic neurons and ameliorates Parkinsonian motor defects.
Yao L; Li W; She H; Dou J; Jia L; He Y; Yang Q; Zhu J; Cápiro NL; Walker DI; Pennell KD; Pang Y; Liu Y; Han Y; Mao Z
J Biol Chem; 2012 Oct; 287(41):34246-55. PubMed ID: 22891246
[TBL] [Abstract][Full Text] [Related]
14. CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's disease.
Waldmeier PC; Spooren WP; Hengerer B
Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):526-37. PubMed ID: 11138845
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.
Guo Z; Xu S; Du N; Liu J; Huang Y; Han M
Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
[TBL] [Abstract][Full Text] [Related]
17. Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity.
Zhang D; Hu X; Wei SJ; Liu J; Gao H; Qian L; Wilson B; Liu G; Hong JS
J Neuroinflammation; 2008 May; 5():21. PubMed ID: 18507839
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
Guo B; Xu D; Duan H; Du J; Zhang Z; Lee SM; Wang Y
Biol Pharm Bull; 2014; 37(2):274-85. PubMed ID: 24305623
[TBL] [Abstract][Full Text] [Related]
19. Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X
Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563
[TBL] [Abstract][Full Text] [Related]
20. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
